Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-22

Clinical Trial Update: Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different frequencies of oral iron dosing in children with Restless Legs Syndrome and Periodic Limb Movement Disorder was terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral iron supplement (ferrous iron)

Snippet

Sponsor: Mayo Clinic | Conditions: Sleep Disorder, Restless Legs Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2024-05-22